PubRank

Michel Marre

Author PubWeight™ 271.43‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008 38.76
2 Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet 2010 23.08
3 Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet 2010 16.96
4 Variation in FTO contributes to childhood obesity and severe adult obesity. Nat Genet 2007 13.62
5 Severe hypoglycemia and risks of vascular events and death. N Engl J Med 2010 8.54
6 Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution. Nat Genet 2010 7.94
7 Genome-wide association study for early-onset and morbid adult obesity identifies three new risk loci in European populations. Nat Genet 2009 6.39
8 A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risk. Nat Genet 2008 5.49
9 Genetic variant near IRS1 is associated with type 2 diabetes, insulin resistance and hyperinsulinemia. Nat Genet 2009 5.43
10 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD). Eur Heart J 2013 5.23
11 Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes. J Am Soc Nephrol 2009 4.43
12 A polymorphism within the G6PC2 gene is associated with fasting plasma glucose levels. Science 2008 4.38
13 Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 1 diabetes (BEGIN Basal-Bolus Type 1): a phase 3, randomised, open-label, treat-to-target non-inferiority trial. Lancet 2012 4.03
14 Intensive glucose control improves kidney outcomes in patients with type 2 diabetes. Kidney Int 2013 3.42
15 Common nonsynonymous variants in PCSK1 confer risk of obesity. Nat Genet 2008 3.24
16 Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals. PLoS Genet 2012 3.21
17 Impact of common type 2 diabetes risk polymorphisms in the DESIR prospective study. Diabetes 2007 2.69
18 The common P446L polymorphism in GCKR inversely modulates fasting glucose and triglyceride levels and reduces type 2 diabetes risk in the DESIR prospective general French population. Diabetes 2008 2.65
19 Follow-up of blood-pressure lowering and glucose control in type 2 diabetes. N Engl J Med 2014 2.64
20 Metformin use and mortality among patients with diabetes and atherothrombosis. Arch Intern Med 2010 2.52
21 Rare MTNR1B variants impairing melatonin receptor 1B function contribute to type 2 diabetes. Nat Genet 2012 2.15
22 Comment on "A common genetic variant is associated with adult and childhood obesity". Science 2007 2.04
23 Post genome-wide association studies of novel genes associated with type 2 diabetes show gene-gene interaction and high predictive value. PLoS One 2008 1.94
24 Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes: New results from the ADVANCE trial. Diabetes Care 2009 1.89
25 Prognostic value of the insertion/deletion polymorphism of the ACE gene in type 2 diabetic subjects: results from the Non-insulin-dependent Diabetes, Hypertension, Microalbuminuria or Proteinuria, Cardiovascular Events, and Ramipril (DIABHYCAR), Diabete de type 2, Nephropathie et Genetique (DIAB2NEPHROGENE), and Survie, Diabete de type 2 et Genetique (SURDIAGENE) studies. Diabetes Care 2008 1.82
26 New susceptibility loci associated with kidney disease in type 1 diabetes. PLoS Genet 2012 1.79
27 A genome-wide association search for type 2 diabetes genes in African Americans. PLoS One 2012 1.72
28 Lowering blood pressure reduces renal events in type 2 diabetes. J Am Soc Nephrol 2009 1.68
29 The genetic susceptibility to type 2 diabetes may be modulated by obesity status: implications for association studies. BMC Med Genet 2008 1.68
30 Combined effects of MC4R and FTO common genetic variants on obesity in European general populations. J Mol Med (Berl) 2009 1.62
31 Implications of diabetes in patients with acute coronary syndromes. The Global Registry of Acute Coronary Events. Arch Intern Med 2004 1.57
32 Adding once-daily lixisenatide for type 2 diabetes inadequately controlled by established basal insulin: a 24-week, randomized, placebo-controlled comparison (GetGoal-L). Diabetes Care 2013 1.55
33 Ferritin and transferrin are associated with metabolic syndrome abnormalities and their change over time in a general population: Data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR). Diabetes Care 2007 1.53
34 Effects of TCF7L2 polymorphisms on obesity in European populations. Obesity (Silver Spring) 2008 1.49
35 TCF7L2 variation predicts hyperglycemia incidence in a French general population: the data from an epidemiological study on the Insulin Resistance Syndrome (DESIR) study. Diabetes 2006 1.45
36 R125W coding variant in TBC1D1 confers risk for familial obesity and contributes to linkage on chromosome 4p14 in the French population. Hum Mol Genet 2008 1.44
37 Adiponectin gene polymorphisms and adiponectin levels are independently associated with the development of hyperglycemia during a 3-year period: the epidemiologic data on the insulin resistance syndrome prospective study. Diabetes 2004 1.44
38 Urinary albumin excretion is a risk factor for diabetes mellitus in men, independently of initial metabolic profile and development of insulin resistance. The DESIR Study. J Hypertens 2008 1.40
39 A composite risk assessment model to screen for gestational diabetes mellitus among Mediterranean women. Int J Gynaecol Obstet 2012 1.37
40 Low water intake and risk for new-onset hyperglycemia. Diabetes Care 2011 1.33
41 Ferritin and transferrin are both predictive of the onset of hyperglycemia in men and women over 3 years: the data from an epidemiological study on the Insulin Resistance Syndrome (DESIR) study. Diabetes Care 2006 1.32
42 Genetic variant in HK1 is associated with a proanemic state and A1C but not other glycemic control-related traits. Diabetes 2009 1.29
43 G-allele of intronic rs10830963 in MTNR1B confers increased risk of impaired fasting glycemia and type 2 diabetes through an impaired glucose-stimulated insulin release: studies involving 19,605 Europeans. Diabetes 2009 1.27
44 Efficacy and safety of sitagliptin versus glipizide in patients with type 2 diabetes and moderate-to-severe chronic renal insufficiency. Diabetes Care 2012 1.24
45 Dairy consumption and the incidence of hyperglycemia and the metabolic syndrome: results from a french prospective study, Data from the Epidemiological Study on the Insulin Resistance Syndrome (DESIR). Diabetes Care 2011 1.24
46 Whole-exome sequencing and high throughput genotyping identified KCNJ11 as the thirteenth MODY gene. PLoS One 2012 1.24
47 Waist circumference and the metabolic syndrome predict the development of elevated albuminuria in non-diabetic subjects: the DESIR Study. J Hypertens 2006 1.21
48 Comparison of waist-to-hip ratio and other obesity indices as predictors of cardiovascular disease risk in people with type-2 diabetes: a prospective cohort study from ADVANCE. Eur J Cardiovasc Prev Rehabil 2011 1.15
49 Hyperglycemia-induced defects in angiogenesis in the chicken chorioallantoic membrane model. Diabetes 2004 1.12
50 ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD - summary. Diab Vasc Dis Res 2014 1.10
51 Association between angiotensin-converting enzyme gene polymorphisms and diabetic nephropathy: case-control, haplotype, and family-based study in three European populations. J Am Soc Nephrol 2007 1.07
52 Analysis of 14 candidate genes for diabetic nephropathy on chromosome 3q in European populations: strongest evidence for association with a variant in the promoter region of the adiponectin gene. Diabetes 2006 1.06
53 Vasopressin increases urinary albumin excretion in rats and humans: involvement of V2 receptors and the renin-angiotensin system. Nephrol Dial Transplant 2003 1.05
54 Low-frequency variants in HMGA1 are not associated with type 2 diabetes risk. Diabetes 2011 1.05
55 Association between large detectable clonal mosaicism and type 2 diabetes with vascular complications. Nat Genet 2013 1.04
56 Analysis of novel risk loci for type 2 diabetes in a general French population: the D.E.S.I.R. study. J Mol Med (Berl) 2008 1.01
57 A rare variant in the visfatin gene (NAMPT/PBEF1) is associated with protection from obesity. Obesity (Silver Spring) 2009 1.01
58 Prediction of kidney-related outcomes in patients with type 2 diabetes. Am J Kidney Dis 2012 0.99
59 Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes. Diabetologia 2014 0.99
60 Comment on: Zhu et al. Fasting plasma glucose at 24-28 weeks to screen for gestational diabetes mellitus: new evidence from China. Diabetes Care 2013;36:2038-2040. Diabetes Care 2013 0.97
61 The PPARG Pro12Ala polymorphism is associated with a decreased risk of developing hyperglycemia over 6 years and combines with the effect of the APM1 G-11391A single nucleotide polymorphism: the Data From an Epidemiological Study on the Insulin Resistance Syndrome (DESIR) study. Diabetes 2006 0.96
62 G/T substitution in intron 1 of the UNC13B gene is associated with increased risk of nephropathy in patients with type 1 diabetes. Diabetes 2008 0.96
63 Relationships between common polymorphisms of adenosine triphosphate-binding cassette transporter A1 and high-density lipoprotein cholesterol and coronary heart disease in a population with type 2 diabetes mellitus. Metabolism 2009 0.96
64 Different patterns of insulin resistance in relatives of type 1 diabetic patients with retinopathy or nephropathy: the Genesis France-Belgium Study. Diabetes Care 2004 0.96
65 The common -866G>A variant in the promoter of UCP2 is associated with decreased risk of coronary artery disease in type 2 diabetic men. Diabetes 2008 0.96
66 European rational approach for the genetics of diabetic complications--EURAGEDIC: patient populations and strategy. Nephrol Dial Transplant 2007 0.96
67 ABCA1 single nucleotide polymorphisms on high-density lipoprotein-cholesterol and overweight: the D.E.S.I.R. study. Obesity (Silver Spring) 2006 0.95
68 Circulating inflammatory markers and the risk of vascular complications and mortality in people with type 2 diabetes and cardiovascular disease or risk factors: the ADVANCE study. Diabetes 2013 0.92
69 Genetic and functional assessment of the role of the rs13431652-A and rs573225-A alleles in the G6PC2 promoter that are strongly associated with elevated fasting glucose levels. Diabetes 2010 0.92
70 Contemporary model for cardiovascular risk prediction in people with type 2 diabetes. Eur J Cardiovasc Prev Rehabil 2011 0.91
71 Kallikrein protects against microalbuminuria in experimental type I diabetes. Kidney Int 2009 0.91
72 What is the contribution of two genetic variants regulating VEGF levels to type 2 diabetes risk and to microvascular complications? PLoS One 2013 0.90
73 Association of sirtuin 1 (SIRT1) gene SNPs and transcript expression levels with severe obesity. Obesity (Silver Spring) 2011 0.90
74 Plasma extracellular superoxide dismutase concentration, allelic variations in the SOD3 gene and risk of myocardial infarction and all-cause mortality in people with type 1 and type 2 diabetes. Cardiovasc Diabetol 2015 0.90
75 Analysis of common PTPN1 gene variants in type 2 diabetes, obesity and associated phenotypes in the French population. BMC Med Genet 2006 0.89
76 Cause-specific mortality in diabetes: recent changes in trend mortality. Eur J Prev Cardiol 2012 0.89
77 Impact of natriuretic peptide clearance receptor (NPR3) gene variants on blood pressure in type 2 diabetes. Diabetes Care 2011 0.89
78 Plasma copeptin and renal outcomes in patients with type 2 diabetes and albuminuria. Diabetes Care 2013 0.88
79 Hyperadiponectinemia is independent of kidney function, diabetes duration, and control in type 1 diabetic patients without microangiopathy. J Clin Endocrinol Metab 2010 0.87
80 Type 2 diabetes-related genetic risk scores associated with variations in fasting plasma glucose and development of impaired glucose homeostasis in the prospective DESIR study. Diabetologia 2014 0.86
81 Selective kinin receptor agonists as cardioprotective agents in myocardial ischemia and diabetes. J Pharmacol Exp Ther 2013 0.86
82 Blood microbiota dysbiosis is associated with the onset of cardiovascular events in a large general population: the D.E.S.I.R. study. PLoS One 2013 0.86
83 Comparison between copeptin and vasopressin in a population from the community and in people with chronic kidney disease. J Clin Endocrinol Metab 2014 0.85
84 Plasma Copeptin and Decline in Renal Function in a Cohort from the Community: The Prospective D.E.S.I.R. Study. Am J Nephrol 2015 0.85
85 Dairy products and the metabolic syndrome in a prospective study, DESIR. J Am Coll Nutr 2011 0.85
86 Evaluation of the association of IGF2BP2 variants with type 2 diabetes in French Caucasians. Diabetes 2008 0.85
87 Allelic variations in superoxide dismutase-1 (SOD1) gene and renal and cardiovascular morbidity and mortality in type 2 diabetic subjects. Mol Genet Metab 2012 0.84
88 Associations of the -344 T>C and the 3097 G>A polymorphisms of CYP11B2 gene with hypertension, type 2 diabetes, and metabolic syndrome in a French population. Am J Hypertens 2010 0.84
89 Functional annotations of diabetes nephropathy susceptibility loci through analysis of genome-wide renal gene expression in rat models of diabetes mellitus. BMC Med Genomics 2009 0.83
90 SORBS1 gene, a new candidate for diabetic nephropathy: results from a multi-stage genome-wide association study in patients with type 1 diabetes. Diabetologia 2014 0.82
91 Type B insulin resistance syndrome associated with an immune reconstitution inflammatory syndrome in an HIV-infected woman. J Clin Endocrinol Metab 2011 0.82
92 The lactase persistence genotype is associated with body mass index and dairy consumption in the D.E.S.I.R. study. Metabolism 2013 0.82
93 Evaluating the association of FAAH common gene variation with childhood, adult severe obesity and type 2 diabetes in the French population. Obes Facts 2008 0.82
94 Allelic variations in superoxide dismutase-1 (SOD1) gene are associated with increased risk of diabetic nephropathy in type 1 diabetic subjects. Mol Genet Metab 2011 0.82
95 Adiponectin multimers and ADIPOQ T45G in coronary artery disease in Caribbean type 2 diabetic subjects of African descent. Obesity (Silver Spring) 2009 0.82
96 Development of a phenotypic method for detection of fecal carriage of OXA-48-producing enterobacteriaceae after incidental detection from clinical specimen. J Clin Microbiol 2011 0.81
97 Evaluating the association of common APOA2 variants with type 2 diabetes. BMC Med Genet 2009 0.81
98 The loss-of-function PCSK9 p.R46L genetic variant does not alter glucose homeostasis. Diabetologia 2015 0.81
99 Fetal exposure to maternal type 1 diabetes is associated with renal dysfunction at adult age. Diabetes 2010 0.81
100 Parental history of type 2 diabetes, TCF7L2 variant and lower insulin secretion are associated with incident hypertension. Data from the DESIR and RISC cohorts. Diabetologia 2013 0.81
101 Thiazolidinedione use is not associated with worse cardiovascular outcomes: a study in 28,332 high risk patients with diabetes in routine clinical practice: brief title: thiazolidinedione use and mortality. Int J Cardiol 2012 0.81
102 Hyperglycaemia in pregnancy in Mediterranean women. Acta Diabetol 2012 0.80
103 Modulation of the renal response to ACE inhibition by ACE insertion/deletion polymorphism during hyperglycemia in normotensive, normoalbuminuric type 1 diabetic patients. Diabetes 2005 0.80
104 Genetic variability at the six transmembrane protein of prostate 2 locus and the metabolic syndrome: the data from an epidemiological study on the Insulin Resistance Syndrome (DESIR) study. J Clin Endocrinol Metab 2010 0.80
105 Death, end-stage renal disease and renal function decline in patients with diabetic nephropathy in French cohorts of type 1 and type 2 diabetes. Diabetologia 2016 0.79
106 Association of ADIPOQ genetic variants and plasma adiponectin isoforms with the risk of incident renal events in type 2 diabetes. Nephrol Dial Transplant 2010 0.79
107 Common variants near BDNF and SH2B1 show nominal evidence of association with snacking behavior in European populations. J Mol Med (Berl) 2013 0.79
108 The association of high-density lipoprotein cholesterol with cancer incidence in type II diabetes: a case of reverse causality? Cancer Epidemiol Biomarkers Prev 2013 0.79
109 Novel susceptibility locus at 22q11 for diabetic nephropathy in type 1 diabetes. PLoS One 2011 0.79
110 Gamma-glutamyltransferase, fatty liver index and hepatic insulin resistance are associated with incident hypertension in two longitudinal studies. J Hypertens 2016 0.78
111 Assessment of patients' and physicians' compliance to an ACE inhibitor treatment based on urinary N-acetyl Ser-Asp-Lys-Pro determination in the Noninsulin-Dependent Diabetes, Hypertension, Microalbuminuria, Proteinuria, Cardiovascular Events, and Ramipril (DIABHYCAR) study. Diabetes Care 2006 0.78
112 Association of common variants in NPPA and NPPB with blood pressure does not translate into kidney damage in a general population study. J Hypertens 2010 0.78
113 Association of vitronectin and plasminogen activator inhibitor-1 levels with the risk of metabolic syndrome and type 2 diabetes mellitus. Results from the D.E.S.I.R. prospective cohort. Thromb Haemost 2011 0.78
114 Effect of insulin detemir dose frequency on clinical outcomes in patients with diabetes in PREDICTIVE. Adv Ther 2009 0.78
115 Does PERISCOPE provide a new perspective on diabetic treatment? JAMA 2008 0.78
116 COMPARISON OF THE LONG-TERM EFFECTS OF LIRAGLUTIDE AND GLIMEPIRIDE MONOTHERAPY ON BONE MINERAL DENSITY IN PATIENTS WITH TYPE 2 DIABETES. Endocr Pract 2015 0.78
117 Secretory granule neuroendocrine protein 1 (SGNE1) genetic variation and glucose intolerance in severe childhood and adult obesity. BMC Med Genet 2007 0.78
118 Glucose control in critically ill patients. N Engl J Med 2009 0.78
119 Smallness for gestational age interacts with high mobility group A2 gene genetic variation to modulate height. Eur J Endocrinol 2009 0.78
120 Tissue kallikrein deficiency, insulin resistance, and diabetes in mouse and man. J Endocrinol 2014 0.77
121 Polymorphisms of the lamina maturation pathway and their association with the metabolic syndrome: the DESIR prospective study. J Mol Med (Berl) 2009 0.77
122 Transforming growth factor-beta 1 production is correlated with genetically determined ACE expression in congenic rats: a possible link between ACE genotype and diabetic nephropathy. Diabetes 2004 0.77
123 Catalase activity, allelic variations in the catalase gene and risk of kidney complications in patients with type 1 diabetes. Diabetologia 2013 0.77
124 Adding liraglutide to oral antidiabetic drug monotherapy: efficacy and weight benefits. Postgrad Med 2009 0.77
125 NMR-based prediction of cardiovascular risk in diabetes. Nat Med 2007 0.77
126 The CETP TaqIB polymorphism is associated with the risk of sudden death in type 2 diabetic patients. Diabetes Care 2007 0.77
127 Efficacy of indapamide SR compared with enalapril in elderly hypertensive patients with type 2 diabetes. Am J Hypertens 2007 0.77
128 Kinins as therapeutic agents in cardiovascular and renal diseases. Curr Pharm Des 2011 0.76
129 Analysis of KLF transcription factor family gene variants in type 2 diabetes. BMC Med Genet 2007 0.76
130 Investigation of the human ANP gene in type 1 diabetic nephropathy: case-control and follow-up studies. Diabetes 2004 0.76
131 Evaluating the association of common PBX1 variants with type 2 diabetes. BMC Med Genet 2008 0.75
132 PROX1 gene CC genotype as a major determinant of early onset of type 2 diabetes in slavic study participants from Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation study. J Hypertens 2017 0.75
133 [Evaluation of a screening programme for diabetic retinopathy (DODIA study)]. Rev Prat 2007 0.75
134 Correction: Genome-wide physical activity interactions in adiposity - A meta-analysis of 200,452 adults. PLoS Genet 2017 0.75
135 [ESC guidelines on diabetes, pre-diabetes and diseases of the cardiovascular system developed in cooperation with the EASD]. Kardiol Pol 2013 0.75
136 YIA 03-01 VALIDATION OF GENETIC DETERMINANTS OF UNMET NEEDS IN THE TREATMENT OF KIDNEY DISEASE IN TYPE-2 DIABETES. J Hypertens 2016 0.75
137 [Utility of nursing consultations after hospitalization for patients on insulin]. Soins 2003 0.75
138 Erratum. Nephrol Dial Transplant 2017 0.75
139 Use of insulin degludec, a new basal insulin with an ultra-long duration of action, in basal-bolus therapy in type 1 and type 2 diabetes. Ann Endocrinol (Paris) 2013 0.75
140 [New trails in diabetology]. Med Sci (Paris) 2003 0.75
141 [Evaluation of a insulin syringe with a security system]. Soins 2003 0.75
142 Obstetric adiposity in the Mediterranean region. Int J Gynaecol Obstet 2013 0.75
143 OS 05-01 PROX1 GENE CC GENOTYPE AS A MAJOR DETERMINANT OF EARLY ONSET OF T2D AND CARDIOVASCULAR COMPLICATIONS IN SLAVIC SUBJECTS FROM ADVANCE STUDY. J Hypertens 2016 0.75
144 OS 05-01 PROX1 GENE CC GENOTYPE AS A MAJOR DETERMINANT OF EARLY ONSET OF T2D AND CARDIOVASCULAR COMPLICATIONS IN SLAVIC SUBJECTS FROM ADVANCE STUDY. J Hypertens 2016 0.75
145 YIA 03-01 VALIDATION OF GENETIC DETERMINANTS OF UNMET NEEDS IN THE TREATMENT OF KIDNEY DISEASE IN TYPE-2 DIABETES. J Hypertens 2016 0.75
146 Side effects and tolerability of combination blood pressure lowering according to blood pressure levels: an analysis of the PROGRESS and ADVANCE trials. J Hypertens 2017 0.75
147 A polymorphism in the angiotensin II type 1 receptor gene has different effects on the risk of diabetic nephropathy in men and women. Mol Genet Metab 2011 0.75